Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Microplastics as vectors for bioaccumulation of hydrophobic organic chemicals in the marine environment: A state-of-the-science review.

Ziccardi LM, Edgington A, Hentz K, Kulacki KJ, Kane Driscoll S.

Environ Toxicol Chem. 2016 Jul;35(7):1667-76. doi: 10.1002/etc.3461. Epub 2016 May 18. Review.

PMID:
27093569
2.

Microscopic investigation of single-wall carbon nanotube uptake by Daphnia magna.

Edgington AJ, Petersen EJ, Herzing AA, Podila R, Rao A, Klaine SJ.

Nanotoxicology. 2014 Aug;8 Suppl 1:2-10. doi: 10.3109/17435390.2013.847504. Epub 2013 Dec 18.

PMID:
24350828
3.

Looking beyond recurrence: comorbidities in cancer survivors.

Edgington A, Morgan MA.

Clin J Oncol Nurs. 2011 Feb;15(1):E3-12. doi: 10.1188/11.CJON.E3-E12.

4.

An LC-MS-MS method for quantitative determination of maraviroc (UK-427,857) in human plasma, urine and cerebrospinal fluid.

Brewer E, Felix T, Clarke P, Edgington A, Muirhead D.

Biomed Chromatogr. 2010 Dec;24(12):1316-23. doi: 10.1002/bmc.1442.

PMID:
21077250
5.

The influence of natural organic matter on the toxicity of multiwalled carbon nanotubes.

Edgington AJ, Roberts AP, Taylor LM, Alloy MM, Reppert J, Rao AM, Mao J, Klaine SJ.

Environ Toxicol Chem. 2010 Nov;29(11):2511-8. doi: 10.1002/etc.309.

PMID:
20865699
6.

Influence of multiwalled carbon nanotubes dispersed in natural organic matter on speciation and bioavailability of copper.

Kim KT, Edgington AJ, Klaine SJ, Cho JW, Kim SD.

Environ Sci Technol. 2009 Dec 1;43(23):8979-84. doi: 10.1021/es900647f.

PMID:
19943676
7.

Determination of a potent urokinase-type plasminogen activator, UK-356,202, in plasma at pg/mL levels using column-switching HPLC and fluorescence detection.

Bayliss MA, Venn RF, Edgington AM, Webster R, Walker DK.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jan 15;877(3):121-6. doi: 10.1016/j.jchromb.2008.11.038. Epub 2008 Dec 3.

PMID:
19119083
8.

PEGylation of somatropin (recombinant human growth hormone): impact on its clearance in humans.

Webster R, Xie R, Didier E, Finn R, Finnessy J, Edgington A, Walker D.

Xenobiotica. 2008 Oct;38(10):1340-51. doi: 10.1080/00498250802413856 .

PMID:
18802875
9.

Pharmacokinetics and clearance processes of UK-279,276 (rNIF) in rat and dog: comparison with human data.

Webster R, Edgington A, Phipps J, Walker D.

Xenobiotica. 2006 Apr;36(4):341-9.

PMID:
16684713
10.
11.

Fluorescence determination of sulphobutylether-beta-cyclodextrin in human plasma by size exclusion chromatography with inclusion complex formation.

Gage R, Venn RF, Bayliss MA, Edgington AM, Roffey SJ, Sorrell B.

J Pharm Biomed Anal. 2000 Jun;22(5):773-80.

PMID:
10815720
12.

Role of sialylation in determining the pharmacokinetics of neutrophil inhibitory factor (NIF) in the Fischer 344 rat.

Webster R, Taberner J, Edgington A, Guhan S, Varghese J, Feeney H, Blocker L, Jezequel SG.

Xenobiotica. 1999 Nov;29(11):1141-55.

PMID:
10598748
13.

Laparoscopic colposuspension. Is it cost-effective?

Loveridge K, Malouf A, Kennedy C, Edgington A, Lam A.

Surg Endosc. 1997 Jul;11(7):762-5.

PMID:
9214328
14.

An evaluation of an adolescent family planning program.

Ralph N, Edgington A.

J Adolesc Health Care. 1983 Sep;4(3):158-62.

PMID:
6629972

Supplemental Content

Loading ...
Support Center